<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550791/bin/fimmu-11-561390-g003.jpg"/> </div> <div class="text-side"> <h1>Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma.</h1> <p>Representative staining patterns of formalin-fixed, paraffin-embedded thin melanoma lesions with CD8- (A), FOXP3- (A), GRZ-B- (B), HLA class I antigen- (C) and PD-L1- (E) specific mAbs. Double IHC staining was performed utilizing CD8- (brown cells) and FOXP3- (red cells) specific mAbs (A). For HLA class I antigen detection tissue sections were IHC stained with a pool of mouse HLA-Aâ€“specific mAb HCA2 and HLA-B/C-specific mAb HC10 (ratio, 1:1). mAbs E7Q5L (IgG2b) and DA1E (IgG) were used as isotype controls for HLA class I antigen (D) and PD-L1 (F) staining, respectively. Magnification is 200X.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33117345/" target="_blank">33117345</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>